AMGEN SAYS FDA HAS EXTENDED REVIEW PERIOD FOR LUMAKRAS IN COMBINATION WITH VECTIBIX FOR TREATING SOME COLORECTAL CANCER PATIENTS

Reuters · 10/18 12:20

Please log in to view news